FSC Wealth Advisors LLC grew its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 32.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 363 shares of the biotechnology company’s stock after buying an additional 88 shares during the quarter. FSC Wealth Advisors LLC’s holdings in Axon Enterprise were worth $216,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Groupama Asset Managment acquired a new position in shares of Axon Enterprise during the third quarter worth approximately $200,000. Massachusetts Financial Services Co. MA acquired a new position in Axon Enterprise during the third quarter worth $120,553,000. International Assets Investment Management LLC acquired a new position in Axon Enterprise during the third quarter worth $871,860,000. Westfield Capital Management Co. LP lifted its stake in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Axon Enterprise by 328.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after buying an additional 111,405 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.
Axon Enterprise Trading Down 0.9 %
Shares of Axon Enterprise stock opened at $604.68 on Tuesday. The stock has a market capitalization of $46.11 billion, a P/E ratio of 156.25, a P/E/G ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a 52-week low of $247.04 and a 52-week high of $698.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock’s 50-day simple moving average is $617.75 and its 200 day simple moving average is $474.21.
Insider Transactions at Axon Enterprise
Analysts Set New Price Targets
Several equities analysts recently weighed in on the stock. Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group raised their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday. Finally, JMP Securities upped their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $524.85.
View Our Latest Research Report on Axon Enterprise
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Insider Buying Explained: What Investors Need to Know
- Insider Selling in Tech Stocks Spikes in Q4
- Why Are These Companies Considered Blue Chips?
- AI Pharma: 2 Paths to AI-Powered Drug Investment
- Want to Profit on the Downtrend? Downtrends, Explained.
- Sizing Up a New Opportunity for NVIDIA Investors
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.